Spire Healthcare Group (LON:SPI – Get Free Report) posted its quarterly earnings data on Wednesday. The company reported GBX (0.50) EPS for the quarter, Digital Look Earnings reports. Spire Healthcare Group had a net margin of 1.04% and a return on equity of 2.22%.
Spire Healthcare Group Stock Performance
SPI stock remained flat at GBX 246.50 during midday trading on Thursday. The company’s stock had a trading volume of 2,665,969 shares, compared to its average volume of 5,431,851. The company has a market capitalization of £987.47 million, a PE ratio of 61.62, a price-to-earnings-growth ratio of 1.06 and a beta of 0.93. Spire Healthcare Group has a 12-month low of GBX 140.80 and a 12-month high of GBX 249. The company has a current ratio of 0.63, a quick ratio of 0.73 and a debt-to-equity ratio of 177.14. The firm has a 50 day moving average price of GBX 238.06 and a 200 day moving average price of GBX 207.59.
Analysts Set New Price Targets
Separately, Royal Bank Of Canada lowered shares of Spire Healthcare Group to a “sector perform” rating and cut their price objective for the company from GBX 300 to GBX 250 in a research report on Monday, September 7th. One equities research analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of GBX 247.50.
Spire Healthcare Group Company Profile
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. The company also provides eye surgery and treatments, family planning, gastroenterology, general medicine, general surgery, haematology, hand surgery, hip and knee treatment, and heart and kidney treatments.
Featured Articles
- Five stocks we like better than Spire Healthcare Group
- Jabil’s Double-Beat and Raise Is a Signal That This Rally Will Continue
- Anthropic’s IPO Could Put Amazon’s and Alphabet’s Paper Profits to the Test
- Microsoft’s AI Spending Didn’t Change—Wall Street’s View of It Did
- Cleared for Takeoff: AAR Corp. Expands Its Aerospace Aftermarket Reach
Receive News & Ratings for Spire Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.
